NCT07367022

Brief Summary

The goal of this study is to evaluate the ability of a portable sleep monitor to detect obstructive sleep apnea in children with autism spectrum disorder (ASD). The main study objectives are to:

  1. 1.Evaluate the correlation between the obstructive apnea-hypopnea index (OAHI) on a portable sleep monitor and an in-laboratory polysomnogram (PSG);
  2. 2.Determine the sensitivity and specificity of a portable sleep monitor to diagnose obstructive sleep apnea (OSA);
  3. 3.Evaluate patient and family preferences for sleep testing.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
8mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress53%
Aug 2025Dec 2026

Study Start

First participant enrolled

August 12, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 17, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 26, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

January 26, 2026

Status Verified

January 1, 2026

Enrollment Period

1.4 years

First QC Date

September 17, 2025

Last Update Submit

January 16, 2026

Conditions

Keywords

Portable Sleep MonitorPolysomnogramChildren with ASDNox T3sSleep Disordered BreathingSleep disorder

Outcome Measures

Primary Outcomes (1)

  • Obstructive Apnea-Hypopnea Index (OAHI) measured from the portable sleep monitor and from the polysomnogram (PSG)

    The OAHI measured from the portable sleep monitor will be compared to the OAHI measured from the PSG, the gold standard test for sleep-disordered breathing, to determine the ability of the portable sleep monitor to diagnose obstructive sleep apnea.

    Baseline

Secondary Outcomes (21)

  • Patient and Family Preferences

    0-3 months after the baseline PSG

  • Insomnia Questionnaire

    +/- 1 week from baseline PSG sleep test

  • Chronotype Questionnaire

    +/- 1 week from baseline PSG sleep test

  • Chronotype Questionnaire

    +/- 1 week from baseline PSG sleep test

  • Chronotype Questionnaire

    +/- 1 week from baseline PSG sleep test

  • +16 more secondary outcomes

Study Arms (1)

Children with ASD testing a portable sleep monitor

Children aged 6-18 years old with autism spectrum disorder concurrently testing a portable sleep monitor (Nox T3s) during their first clinical polysomnogram. Children and their caregivers may also complete a qualitative interview about sleep testing preferences after their sleep test.

Device: Portable sleep monitor (Nox T3s)

Interventions

Participants will test the Nox T3s portable sleep monitor concurrently during their in-hospital clinical polysomnogram.

Children with ASD testing a portable sleep monitor

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children who are undergoing a clinical PSG at British Columbia's Children's Hospital in Vancouver, Canada.

You may qualify if:

  • Children between 6 to 18 years of age, AND;
  • Children diagnosed with autism spectrum disorder, AND;
  • Children who will be undergoing a polysomnogram (PSG) for the first time, AND;
  • Caregiver willing to complete questionnaires about child's sleep and behavior

You may not qualify if:

  • Children who are currently using respiratory therapy
  • Children who have previously completed a PSG
  • Caregiver unwilling to complete questionnaires about child's sleep and behavior

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

British Columbia Children's Hospital

Vancouver, British Columbia, V6H 3N1, Canada

RECRUITING

MeSH Terms

Conditions

Autism Spectrum DisorderSleep Apnea, ObstructiveSleep Apnea SyndromesSleep Wake Disorders

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Lena J Xiao, MD MSc

CONTACT

Macyn LY Leung, MSc

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Assistant Professor

Study Record Dates

First Submitted

September 17, 2025

First Posted

January 26, 2026

Study Start

August 12, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

January 26, 2026

Record last verified: 2026-01

Locations